Standout Papers
Immediate Impact
74 standout
Citing Papers
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
Works of Nuala Peter being referenced
Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nuala Peter | 673 | 694 | 62 | 145 | 9 | 899 | |
| Tim Brighton | 356 | 442 | 47 | 183 | 22 | 853 | |
| Frederick A. Meyers | 337 | 592 | 26 | 134 | 11 | 879 | |
| P Stevens | 273 | 420 | 19 | 264 | 22 | 993 | |
| F Petrobelli | 355 | 375 | 10 | 147 | 19 | 813 | |
| Eugenio Bucherini | 526 | 760 | 10 | 378 | 28 | 928 | |
| Robert G. Lerner | 460 | 542 | 10 | 294 | 22 | 808 | |
| J.F. Timp | 490 | 780 | 3 | 184 | 15 | 974 | |
| Colin Chesterman | 555 | 719 | 7 | 339 | 4 | 918 | |
| Katrina Mott | 702 | 361 | 47 | 66 | 16 | 1.2k | |
| Anne-Marie Prabulos | 444 | 524 | 186 | 162 | 5 | 907 |
All Works
Loading papers...